[
  {
    "id": 341,
    "question": "Patient presented with weakness, MRI brain showed ischemic infarction in superior cerebellar artery, what would be expected to be seen?",
    "option_a": "Ipsilateral Horner/ ptosis",
    "option_b": "Ipsilateral fourth nerve palsy",
    "option_c": "?",
    "option_d": "?",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThe superior cerebellar artery (SCA) supplies the superior aspect of the cerebellum, which is central to coordination, balance, and fine motor control. Infarction in this vascular territory typically produces cerebellar signs, such as ipsilateral limb ataxia, dysmetria, and dysdiadochokinesia. The core concept is localizing neurological deficits based on vascular territories within the posterior fossa.\n\n**Pathophysiology**\n\nAn ischemic stroke in the SCA territory leads to infarction of cerebellar tissue. This results in edema and loss of function in the regions controlling coordination. Although the SCA may supply parts of the cerebellar peduncles and, in some cases, adjacent regions of the midbrain, isolated involvement of cranial nerve IV (which governs the superior oblique muscle and mediates downward gaze) is much less typical. Rather, the damage mainly disrupts cerebellar circuits.\n\n**Clinical Correlation**\n\nPatients with SCA infarcts commonly present with ipsilateral cerebellar signs including limb ataxia and dysmetria. They may have disturbances in balance and coordination, which can manifest as a wide-based gait, tremor, or difficulty with rapid alternating movements. A fourth nerve palsy, which would produce vertical diplopia and difficulty with downward gaze, is more characteristic of a specific midbrain lesion rather than a pure cerebellar (SCA) stroke.\n\n**Diagnostic Approach**\n\nWhen evaluating a patient with suspected posterior circulation stroke, the differential diagnoses include infarcts in the PICA territory (lateral medullary syndrome with features such as ipsilateral Horner syndrome and loss of pain and temperature on the face), AICA infarcts (which can involve facial nerve deficits and hearing loss), and midbrain strokes. Neuroimaging (MRI) is key to localizing the vascular territory and differentiating between these entities.\n\n**Management Principles**\n\nStandard management of ischemic stroke includes prompt evaluation for thrombolytic eligibility and secondary prevention measures (antiplatelet therapy, risk factor management, and rehabilitation). In cerebellar strokes, supportive care is crucial due to the risk of edema and compression of adjacent structures. Although decompressive strategies may be needed in large infarcts, in SCA strokes the focus is usually on symptomatic and rehabilitative management. In pregnant or lactating patients, thrombolytic and antithrombotic therapies are administered following established guidelines (with careful risk\u2010benefit analysis) and imaging is used to confirm infarct location.\n\n**Option Analysis**\n\nOption A (Ipsilateral Horner/ptosis) is more indicative of a lateral medullary (PICA) infarct, involving disruption of the descending sympathetic fibers. Option B (Ipsilateral fourth nerve palsy) points toward a midbrain lesion affecting the trochlear nerve. Neither of these options captures the classic presentation of an SCA infarct. The expected clinical finding would be cerebellar dysfunction, such as ipsilateral limb ataxia or other markers of cerebellar involvement, which we assume corresponds to option C (though not explicitly listed).\n\n**Clinical Pearls**\n\n1. SCA strokes typically produce ipsilateral cerebellar signs like ataxia and dysmetria. 2. Isolated cranial nerve deficits (such as a fourth nerve palsy) are usually linked to midbrain or other brainstem lesions rather than pure cerebellar infarcts.\n\n**Current Evidence**\n\nRecent stroke management guidelines emphasize early recognition and localization of posterior circulation strokes using MRI. Studies consistently show that cerebellar infarcts in the SCA territory manifest with coordination deficits rather than isolated ocular motor nerve palsies. There remains active research in optimizing early rehabilitative interventions for cerebellar strokes.",
    "exam_year": "2024",
    "exam_type": "Part II"
  },
  {
    "id": 342,
    "question": "Elderly patient brought to emergency by his family who saw him unresponsive in bed, last time seen well was 1 day ago, CT brain attached showing large infarction area (Right MCA) with midline shift, what is the most important thing to do?",
    "option_a": "decompressive craniectomy",
    "option_b": "admission to stroke unit",
    "option_c": "?",
    "option_d": "?",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThe superior cerebellar artery (SCA) supplies the superior aspect of the cerebellum, which is central to coordination, balance, and fine motor control. Infarction in this vascular territory typically produces cerebellar signs, such as ipsilateral limb ataxia, dysmetria, and dysdiadochokinesia. The core concept is localizing neurological deficits based on vascular territories within the posterior fossa.\n\n**Pathophysiology**\n\nAn ischemic stroke in the SCA territory leads to infarction of cerebellar tissue. This results in edema and loss of function in the regions controlling coordination. Although the SCA may supply parts of the cerebellar peduncles and, in some cases, adjacent regions of the midbrain, isolated involvement of cranial nerve IV (which governs the superior oblique muscle and mediates downward gaze) is much less typical. Rather, the damage mainly disrupts cerebellar circuits.\n\n**Clinical Correlation**\n\nPatients with SCA infarcts commonly present with ipsilateral cerebellar signs including limb ataxia and dysmetria. They may have disturbances in balance and coordination, which can manifest as a wide-based gait, tremor, or difficulty with rapid alternating movements. A fourth nerve palsy, which would produce vertical diplopia and difficulty with downward gaze, is more characteristic of a specific midbrain lesion rather than a pure cerebellar (SCA) stroke.\n\n**Diagnostic Approach**\n\nWhen evaluating a patient with suspected posterior circulation stroke, the differential diagnoses include infarcts in the PICA territory (lateral medullary syndrome with features such as ipsilateral Horner syndrome and loss of pain and temperature on the face), AICA infarcts (which can involve facial nerve deficits and hearing loss), and midbrain strokes. Neuroimaging (MRI) is key to localizing the vascular territory and differentiating between these entities.\n\n**Management Principles**\n\nStandard management of ischemic stroke includes prompt evaluation for thrombolytic eligibility and secondary prevention measures (antiplatelet therapy, risk factor management, and rehabilitation). In cerebellar strokes, supportive care is crucial due to the risk of edema and compression of adjacent structures. Although decompressive strategies may be needed in large infarcts, in SCA strokes the focus is usually on symptomatic and rehabilitative management. In pregnant or lactating patients, thrombolytic and antithrombotic therapies are administered following established guidelines (with careful risk\u2010benefit analysis) and imaging is used to confirm infarct location.\n\n**Option Analysis**\n\nOption A (Ipsilateral Horner/ptosis) is more indicative of a lateral medullary (PICA) infarct, involving disruption of the descending sympathetic fibers. Option B (Ipsilateral fourth nerve palsy) points toward a midbrain lesion affecting the trochlear nerve. Neither of these options captures the classic presentation of an SCA infarct. The expected clinical finding would be cerebellar dysfunction, such as ipsilateral limb ataxia or other markers of cerebellar involvement, which we assume corresponds to option C (though not explicitly listed).\n\n**Clinical Pearls**\n\n1. SCA strokes typically produce ipsilateral cerebellar signs like ataxia and dysmetria. 2. Isolated cranial nerve deficits (such as a fourth nerve palsy) are usually linked to midbrain or other brainstem lesions rather than pure cerebellar infarcts.\n\n**Current Evidence**\n\nRecent stroke management guidelines emphasize early recognition and localization of posterior circulation strokes using MRI. Studies consistently show that cerebellar infarcts in the SCA territory manifest with coordination deficits rather than isolated ocular motor nerve palsies. There remains active research in optimizing early rehabilitative interventions for cerebellar strokes.",
    "exam_year": "2024",
    "exam_type": "Part II"
  },
  {
    "id": 343,
    "question": "A 45-year-old man suffers bilateral vertebral artery dissections and multiple brain stem and cerebellar infarctions causing right hemiplegia, dysarthria, and dysphagia. Two years later he returns, complaining of oscillopsia at rest. (Not mentioned: Examination of his eyes reveals a 1-Hz pendular oscillation comprising conjugate vertical and torsional components; the right eye intorts as",
    "option_a": "(Ipsilateral Horner/ptosis) is more indicative of a lateral medullary (PICA) infarct, involving disruption of the descending sympathetic fibers. Option B (Ipsilateral fourth nerve palsy) points toward a midbrain lesion affecting the trochlear nerve. Neither of these options captures the classic presentation of an SCA infarct. The expected clinical finding would be cerebellar dysfunction, such as ipsilateral limb ataxia or other markers of cerebellar involvement, which we assume corresponds to option C (though not explicitly listed).",
    "option_b": "",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThe superior cerebellar artery (SCA) supplies the superior aspect of the cerebellum, which is central to coordination, balance, and fine motor control. Infarction in this vascular territory typically produces cerebellar signs, such as ipsilateral limb ataxia, dysmetria, and dysdiadochokinesia. The core concept is localizing neurological deficits based on vascular territories within the posterior fossa.\n\n**Pathophysiology**\n\nAn ischemic stroke in the SCA territory leads to infarction of cerebellar tissue. This results in edema and loss of function in the regions controlling coordination. Although the SCA may supply parts of the cerebellar peduncles and, in some cases, adjacent regions of the midbrain, isolated involvement of cranial nerve IV (which governs the superior oblique muscle and mediates downward gaze) is much less typical. Rather, the damage mainly disrupts cerebellar circuits.\n\n**Clinical Correlation**\n\nPatients with SCA infarcts commonly present with ipsilateral cerebellar signs including limb ataxia and dysmetria. They may have disturbances in balance and coordination, which can manifest as a wide-based gait, tremor, or difficulty with rapid alternating movements. A fourth nerve palsy, which would produce vertical diplopia and difficulty with downward gaze, is more characteristic of a specific midbrain lesion rather than a pure cerebellar (SCA) stroke.\n\n**Diagnostic Approach**\n\nWhen evaluating a patient with suspected posterior circulation stroke, the differential diagnoses include infarcts in the PICA territory (lateral medullary syndrome with features such as ipsilateral Horner syndrome and loss of pain and temperature on the face), AICA infarcts (which can involve facial nerve deficits and hearing loss), and midbrain strokes. Neuroimaging (MRI) is key to localizing the vascular territory and differentiating between these entities.\n\n**Management Principles**\n\nStandard management of ischemic stroke includes prompt evaluation for thrombolytic eligibility and secondary prevention measures (antiplatelet therapy, risk factor management, and rehabilitation). In cerebellar strokes, supportive care is crucial due to the risk of edema and compression of adjacent structures. Although decompressive strategies may be needed in large infarcts, in SCA strokes the focus is usually on symptomatic and rehabilitative management. In pregnant or lactating patients, thrombolytic and antithrombotic therapies are administered following established guidelines (with careful risk\u2010benefit analysis) and imaging is used to confirm infarct location.\n\n**Option Analysis**\n\nOption A (Ipsilateral Horner/ptosis) is more indicative of a lateral medullary (PICA) infarct, involving disruption of the descending sympathetic fibers. Option B (Ipsilateral fourth nerve palsy) points toward a midbrain lesion affecting the trochlear nerve. Neither of these options captures the classic presentation of an SCA infarct. The expected clinical finding would be cerebellar dysfunction, such as ipsilateral limb ataxia or other markers of cerebellar involvement, which we assume corresponds to option C (though not explicitly listed).\n\n**Clinical Pearls**\n\n1. SCA strokes typically produce ipsilateral cerebellar signs like ataxia and dysmetria. 2. Isolated cranial nerve deficits (such as a fourth nerve palsy) are usually linked to midbrain or other brainstem lesions rather than pure cerebellar infarcts.\n\n**Current Evidence**\n\nRecent stroke management guidelines emphasize early recognition and localization of posterior circulation strokes using MRI. Studies consistently show that cerebellar infarcts in the SCA territory manifest with coordination deficits rather than isolated ocular motor nerve palsies. There remains active research in optimizing early rehabilitative interventions for cerebellar strokes.",
    "exam_year": "2024",
    "exam_type": "Part II"
  },
  {
    "id": 344,
    "question": "Elderly patient presented with swallowing difficulty, examination found deviation of uvula to left side, Brain MRI reported brainstem infarction, what would be an expected symptom?",
    "option_a": "Right Horner (or Ptosis)",
    "option_b": "Left horror",
    "option_c": "Left hand ataxia",
    "option_d": "Right LL sensory loss",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nThe patient\u2019s presentation with dysphagia and uvula deviation indicates involvement of the vagus nerve (CN X) motor fibers, particularly those from the nucleus ambiguus. In brainstem infarctions (especially lateral medullary or Wallenberg syndrome), a lesion on one side leads to weakness of the affected palatal muscles, causing the uvula to deviate toward the intact side. In this case, a uvula deviating to the left implies a right-sided lesion. One of the expected associated findings in a right lateral medullary infarction is an ipsilateral (right) Horner syndrome due to disruption of the descending sympathetic fibers.\n\n**Pathophysiology**\n\nIn lateral medullary (Wallenberg) syndrome, occlusion of the posterior inferior cerebellar artery (PICA) leads to infarction of the lateral aspect of the medulla. This region contains the nucleus ambiguus (affecting CN X and IX, leading to dysphagia and palatal weakness), the spinal trigeminal nucleus (affecting facial pain and temperature sensation), descending sympathetic fibers (leading to ipsilateral Horner syndrome), and portions of the spinothalamic tract (producing contralateral pain and temperature loss).\n\n**Clinical Correlation**\n\nElderly patients are predisposed to vascular events due to underlying atherosclerotic disease. When presenting with acute dysphagia and palatal abnormalities (such as uvula deviation), brainstem infarction should be considered. The lateral medullary syndrome is classically associated with these cranial nerve deficits, and the presence of an ipsilateral Horner syndrome (right side in this scenario) supports the diagnosis.\n\n**Diagnostic Approach**\n\nDiagnosis is supported by neuroimaging (MRI) confirming a brainstem infarction. A thorough neurological examination helps localize the lesion: uvula deviation indicates a CN X palsy, while additional findings such as ipsilateral Horner syndrome, contralateral loss of pain and temperature sensation in the body, and possible cerebellar signs further refine the diagnosis. Differential diagnoses include other brainstem stroke syndromes such as lateral pontine syndrome, but the combination of dysphagia, uvula deviation, and sympathetic disruption is most in keeping with a lateral medullary (Wallenberg) syndrome.\n\n**Management Principles**\n\nManagement of brainstem infarction follows standard acute ischemic stroke protocols, including evaluation for thrombolytic therapy (if within the window period) and supportive care (managing dysphagia, preventing aspiration, blood pressure control, and early rehabilitation). Special considerations in pregnancy involve a careful risk-benefit analysis for thrombolysis and imaging (non-contrast MRI is preferred), while in lactating patients, most acute stroke therapies (e.g., aspirin, heparin) are considered compatible with breastfeeding. Multidisciplinary management is crucial.\n\n**Option Analysis**\n\nOption A (Right Horner syndrome) is the most consistent with a right-sided lateral medullary infarct. Option B (Left Horner syndrome) would be inconsistent with the lateralization indicated by the uvula deviation. Option C (Left hand ataxia) does not fit the typical distribution of deficits seen in this syndrome, and Option D (Right lower limb sensory loss) misrepresents the expected pattern, as contralateral pain/temperature loss would more likely be diffusely distributed rather than isolated to the lower limb.\n\n**Clinical Pearls**\n\n\u2022 Uvula deviation away from the lesion side is a key sign of CN X dysfunction; it helps localize the lesion in brainstem infarcts.  \u2022 In lateral medullary syndrome, look for ipsilateral Horner syndrome, dysphagia, and contralateral loss of pain and temperature sensation.  \u2022 A detailed neurological exam can provide significant localization clues even before imaging is obtained.\n\n**Current Evidence**\n\nContemporary guidelines emphasize rapid recognition and treatment of acute stroke syndromes. Thrombolytic therapy within the approved time window, rigorous secondary stroke prevention, and multidisciplinary rehabilitation remain the cornerstones of modern management. In specialized populations such as pregnant or lactating patients, customization of treatment modalities to minimize risk while ensuring efficacy is guided by current consensus statements and research.",
    "exam_year": "2024",
    "exam_type": "Part II",
    "image_url": "page_4.png"
  },
  {
    "id": 345,
    "question": "Elderly presented with 6 hours right sided weakness including arm, leg and face with mild dysarthria. Brain CT attached showing acute left internal capsule infarction. What is the earlier finding of brain cell ischemia?",
    "option_a": "Astrocyte fragmentations",
    "option_b": "Cells or neuronal swelling",
    "option_c": "Microglial proliferation",
    "option_d": "?",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn the setting of acute ischemia, the earliest microscopic finding is cytotoxic edema, which is manifested as cellular (neuronal) swelling. This reflects the failure of the cell\u2019s energy-dependent ionic pumps due to ischemia.\n\n**Pathophysiology**\n\nWhen blood flow is interrupted, ATP production drops. Consequently, the Na+/K+ ATPase fails, causing an influx of sodium and water into the cell. Neuronal swelling (cytotoxic edema) ensues within minutes, making it one of the first indicators of cellular injury. Later changes such as astrocytic fragmentation and microglial proliferation occur as the ischemic cascade progresses.\n\n**Clinical Correlation**\n\nClinically, early ischemic changes can be subtle and may not be immediately visible on imaging. However, the underlying process of cell swelling correlates with the clinical manifestations of stroke (e.g., contralateral weakness, dysarthria) and the evolution of tissue damage seen in later imaging.\n\n**Diagnostic Approach**\n\nDiagnosis is based on clinical presentation and imaging. Differential diagnoses include hemorrhagic stroke (ruled out by CT), hypoglycemia-related deficits, and transient ischemic attacks. Early CT changes are subtle; advanced imaging like MRI diffusion-weighted imaging can help detect early ischemia.\n\n**Management Principles**\n\nManagement of acute ischemic stroke focuses on timely reperfusion if within the therapeutic window, supportive care, and secondary prevention. There is no intervention to reverse cellular swelling immediately, but rapid reperfusion (via IV tPA or endovascular intervention if indicated) is vital. For patients who are pregnant or lactating, the benefits of reperfusion therapy must be balanced against potential risks, though tPA is generally considered if indicated.\n\n**Option Analysis**\n\nOption A (Astrocyte fragmentations) and Option C (Microglial proliferation) represent later histopathological events. Option B (Cells or neuronal swelling) correctly identifies the earliest change in ischemia.\n\n**Clinical Pearls**\n\n1. Cytotoxic edema is the earliest marker of neuronal injury in stroke. 2. Early signs of ischemia may not be apparent on CT and might require advanced imaging. 3. Time is brain: early detection and management are crucial.\n\n**Current Evidence**\n\nRecent literature stress the importance of early intervention in ischemic stroke and the role of advanced neuroimaging in detecting early cellular changes. New research continues to emphasize optimizing reperfusion strategies even when cellular injury is already underway.",
    "exam_year": "2024",
    "exam_type": "Part II",
    "image_url": "page_2.png"
  },
  {
    "id": 346,
    "question": "Patient presented with 6 hours right sided weakness including arm, leg and face with mild dysarthria. Brain CT showed acute left internal capsule infarction. What is the next step?",
    "option_a": "IV tpa",
    "option_b": "DAPT",
    "option_c": "Aspirin",
    "option_d": "?",
    "option_e": "",
    "correct_answer": "C",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn ischemic stroke management, timely initiation of antiplatelet therapy is crucial after the window for thrombolysis has passed. Aspirin is a cornerstone medication used to inhibit platelet aggregation and reduce the risk of further thrombotic events.\n\n**Pathophysiology**\n\nAspirin inhibits cyclooxygenase (COX-1), decreasing thromboxane A2 production, a potent aggregator of platelets. This reduces platelet activation and aggregation, thereby limiting the propagation of clot formation in cerebral vessels.\n\n**Clinical Correlation**\n\nPatients presenting with stroke symptoms outside the window for thrombolytic therapy (typically 4.5 hours) are managed with antiplatelet therapy. Aspirin not only helps in preventing clot extension but also reduces the risk of early recurrent stroke.\n\n**Diagnostic Approach**\n\nThe diagnosis is primarily clinical corroborated by non-contrast CT to rule out hemorrhage. Differential considerations include hemorrhagic stroke (where aspirin is contraindicated) and stroke mimics like seizures or migraines.\n\n**Management Principles**\n\nFirst-line management for ischemic stroke within the therapeutic window is IV tPA; however, for patients presenting after the window, aspirin is initiated (usually a 160-325 mg loading dose). Dual antiplatelet therapy (DAPT) with aspirin and clopidogrel may be considered in minor strokes or high-risk transient ischemic attacks, particularly within the first 21 days. In pregnancy, low-dose aspirin is considered safe and is used for prevention and treatment in selected cases, with appropriate risk-benefit analysis.\n\n**Option Analysis**\n\nOption A (IV tPA) is contraindicated beyond the typical window. Option B (DAPT) might be appropriate in minor stroke or TIA but is not the standard immediate management for a moderate to severe stroke in this scenario. Option C (Aspirin) is appropriate for a stroke presenting at 6 hours.\n\n**Clinical Pearls**\n\n1. Aspirin should be initiated as soon as hemorrhage is excluded. 2. The therapeutic window for IV tPA is generally within 4.5 hours of symptom onset. 3. Early initiation of antiplatelet therapy improves outcomes in ischemic stroke.\n\n**Current Evidence**\n\nRecent guidelines continue to support the use of aspirin for acute stroke management outside the IV tPA window. Studies have further refined the use of DAPT in select populations, particularly demonstrating benefits in minor strokes and TIAs.",
    "exam_year": "2024",
    "exam_type": "Part II",
    "image_url": "page_2.png"
  },
  {
    "id": 347,
    "question": "Stroke patient presented within window brain Ct and CTA normal. NIHS 16 with BP200/140 what is next step.",
    "option_a": "Drop BP below 185/110 then give tPA",
    "option_b": "Cut perfusion",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn acute ischemic stroke requiring thrombolytic therapy, it is critical to ensure blood pressure is within a safe range prior to administration to minimize the risk of hemorrhagic transformation.\n\n**Pathophysiology**\n\nHigh blood pressure increases the risk of blood vessel rupture during thrombolysis, potentially leading to intracerebral hemorrhage. The standard is to control elevated blood pressure (target <185/110 mmHg) before administering IV tPA.\n\n**Clinical Correlation**\n\nA patient presenting with a high NIHSS score and blood pressure above recommended thresholds must have their blood pressure lowered to mitigate the risk associated with thrombolytic therapy. Failure to control blood pressure can lead to catastrophic hemorrhagic complications.\n\n**Diagnostic Approach**\n\nDiagnosis involves clinical evaluation and imaging confirmation of ischemic stroke. Differential diagnoses include hemorrhagic stroke (which would contraindicate tPA), subarachnoid hemorrhage, and stroke mimics. Continuous blood pressure monitoring is essential.\n\n**Management Principles**\n\nFirst-line therapy for patients within the tPA window with ischemic stroke is IV tPA; however, only after blood pressure is lowered to below 185/110 mmHg using IV antihypertensives (e.g., labetalol, nicardipine). In patients with severe hypertension, blood pressure control is paramount. In pregnant patients, blood pressure management must be careful given fetal considerations, with medications such as labetalol being preferred due to safety profiles in pregnancy and lactation.\n\n**Option Analysis**\n\nOption A (Drop BP below 185/110 then give tPA) is correct according to current guidelines. Option B (Cut perfusion) is nonspecific and not part of stroke management protocols.\n\n**Clinical Pearls**\n\n1. Always check blood pressure before tPA administration; targets are <185/110 mmHg. 2. Rapid blood pressure control with appropriate IV medications is mandatory pre-thrombolysis. 3. Hypertensive emergency in stroke requires balancing cerebral perfusion and risk of hemorrhage.\n\n**Current Evidence**\n\nLatest guidelines reinforce the necessity of strict blood pressure control before IV tPA administration in acute ischemic stroke. Ongoing studies address optimal management strategies for hypertensive emergencies in the context of stroke treatment.",
    "exam_year": "2018",
    "exam_type": "Promotion",
    "image_url": "page_2.png"
  },
  {
    "id": 348,
    "question": "Elderly with quadriplegia, horizontal gaze palsy with spared vertical gaze, localization:",
    "option_a": "Pons",
    "option_b": "Thalamus",
    "option_c": "",
    "option_d": "",
    "option_e": "",
    "correct_answer": "A",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nLocalization of brainstem lesions is based on the pattern of motor deficits and cranial nerve involvement. In this case, quadriplegia with horizontal gaze palsy and spared vertical gaze suggests a pontine involvement.\n\n**Pathophysiology**\n\nThe pons harbors important motor tracts and cranial nerve nuclei including the abducens nucleus and the paramedian pontine reticular formation (PPRF), which coordinate horizontal gaze. A lesion in the pons can disrupt these horizontal gaze centers while leaving the vertical gaze centers in the midbrain unaffected.\n\n**Clinical Correlation**\n\nClinically, patients with pontine lesions often present with locked-in syndrome or severe weakness in all four limbs (quadriplegia), along with specific deficits in horizontal eye movements while vertical movements remain intact. This constellation of findings strongly localizes the lesion to the pons.\n\n**Diagnostic Approach**\n\nLocalization is achieved through detailed neurological examination and supported by imaging studies such as MRI. Differential diagnoses include midbrain lesions (which typically affect vertical gaze) and thalamic lesions (which do not usually cause gaze palsies), helping narrow the diagnosis to a pontine lesion.\n\n**Management Principles**\n\nManagement of brainstem strokes involves supportive care, management of complications, and secondary prevention measures (like antiplatelet therapy, blood pressure control, and cholesterol management). In the acute setting, reperfusion therapy may be considered if the patient presents within the therapeutic window. For pregnant or lactating patients, treatment considerations include the safety profile of medications (e.g., low-dose aspirin) and supportive measures.\n\n**Option Analysis**\n\nOption A (Pons) is correct because quadriplegia with isolated horizontal gaze palsy is consistent with a pontine lesion. Option B (Thalamus) does not explain the specific pattern of gaze abnormality or quadriplegia.\n\n**Clinical Pearls**\n\n1. In pontine strokes, horizontal gaze palsy with spared vertical gaze is a key localizing sign. 2. Quadriplegia with these eye findings often indicates a lesion in the ventral pons. 3. Detailed neuro-ophthalmologic examination is essential for accurate localization.\n\n**Current Evidence**\n\nRecent neuroimaging advances continue to improve localization of brainstem strokes. Current guidelines stress early recognition and supportive management while research into neuroprotective treatments and reperfusion strategies is ongoing.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "id": 349,
    "question": "Stroke patient presented within the window glucose 300 platelet 45000 BP 170/90 IV tPA not given, what the contraindication:",
    "option_a": "Glu",
    "option_b": "Platelet count",
    "option_c": "BP",
    "option_d": "",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nIn acute ischemic stroke, intravenous thrombolytic therapy (IV tPA) is administered within a narrow time window. However, strict inclusion/exclusion criteria must be met to minimize the risk of hemorrhagic complications. One key contraindication is a significantly low platelet count.\n\n**Pathophysiology**\n\nThrombolytic agents work by dissolving clots but they also carry the risk of causing bleeding. A sufficiently low platelet count (<100,000/\u00b5L) impairs clot formation and hemostasis, substantially increasing the risk of hemorrhage after tPA administration. Although elevated blood glucose or moderately high blood pressure can be concerning, they are not absolute contraindications as long as they are managed appropriately.\n\n**Clinical Correlation**\n\nIn the clinical scenario, the patient\u2019s blood pressure (170/90 mmHg) is below the critical threshold (usually 185/110 mmHg) for tPA use, and while a blood glucose of 300 mg/dL is high, hyperglycemia is not an absolute contraindication. The platelet count of 45,000/\u00b5L, however, is markedly low and represents an absolute contraindication because it significantly elevates the risk of bleeding complications.\n\n**Diagnostic Approach**\n\nBefore administering tPA in stroke patients, a rapid evaluation is needed\u2014this includes noncontrast CT brain imaging to rule out hemorrhage and laboratory tests (including platelet count, coagulation profile, and serum glucose). Differential considerations include ruling out hemorrhagic stroke, identifying metabolic abnormalities, and ensuring no contraindicating lab abnormalities are present.\n\n**Management Principles**\n\nAccording to the latest AHA/ASA guidelines, the presence of a platelet count less than 100,000/\u00b5L is an absolute contraindication to IV tPA. In a patient with low platelet count, tPA is withheld. Management then focuses on supportive care, possible alternative interventions, and addressing the cause of thrombocytopenia. In pregnant or lactating patients, similar contraindications apply, and alternative management strategies should be considered with multidisciplinary input.\n\n**Option Analysis**\n\nOption A (Glucose) is not an absolute contraindication as high blood sugar is common in acute stroke but does not preclude tPA if managed. Option B indicating the low platelet count is the contraindication because a count of 45,000/\u00b5L is far below the safe threshold. Option C (BP) is acceptable since 170/90 mmHg is within limits. Option D is missing.\n\n**Clinical Pearls**\n\n1. Always confirm laboratory values (especially platelet count) prior to thrombolysis in stroke. 2. A platelet count <100,000/\u00b5L is an absolute contraindication for tPA due to the high risk of hemorrhagic conversion. 3. Elevated blood pressure may be managed acutely, and hyperglycemia, while concerning, is not an exclusion if corrected.\n\n**Current Evidence**\n\nRecent guidelines from the AHA/ASA continue to emphasize that a platelet count below 100,000/\u00b5L contraindicates tPA. Research and clinical audits have consistently demonstrated an increased hemorrhagic risk when tPA is administered in the context of thrombocytopenia.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  },
  {
    "id": 350,
    "question": "One of the ICA branches:",
    "option_a": "SCA",
    "option_b": "Posterior Communicating",
    "option_c": "Ant com",
    "option_d": "AICA",
    "option_e": "",
    "correct_answer": "B",
    "subspecialty": "Vascular Neurology/Stroke",
    "explanation": "**Conceptual Foundation**\n\nA clear understanding of cerebrovascular anatomy is crucial in neurology. The internal carotid artery (ICA) is a major supplier of blood to the brain and gives off several branches that contribute to the Circle of Willis.\n\n**Pathophysiology**\n\nICA branches are responsible for distributing blood flow to key cerebral regions. The posterior communicating artery (PCOM) is one of these branches; it provides an important collateral pathway between the anterior and posterior circulations, potentially impacting stroke outcomes.\n\n**Clinical Correlation**\n\nKnowledge of ICA branches is essential for evaluating vascular pathologies such as aneurysms and interpreting collateral circulation in stroke. Aneurysms frequently occur at branching points within the Circle of Willis, including the PCOM.\n\n**Diagnostic Approach**\n\nWhen evaluating patients with suspected cerebrovascular disease, imaging modalities such as CT angiography or MR angiography are used to delineate vascular anatomy and identify anomalies. Differential considerations include differentiating between branches of the ICA versus those arising from the vertebrobasilar system.\n\n**Management Principles**\n\nWhile this question focuses on anatomy rather than active management, it is important to recognize vascular branches when planning interventions, such as in the setting of aneurysmal clipping or endovascular therapy. In pregnant patients, radiation exposure during imaging is minimized through appropriate shielding and the use of MRI when feasible.\n\n**Option Analysis**\n\nOption A (SCA) is incorrect because the superior cerebellar artery is typically a branch of the basilar artery. Option B (Posterior Communicating) is correct as it is a branch of the ICA. Option C (Anterior communicating) is not a branch of the ICA but connects the two anterior cerebral arteries. Option D (AICA) is incorrect because the anterior inferior cerebellar artery arises from the basilar artery.\n\n**Clinical Pearls**\n\n1. The posterior communicating artery is a pivotal branch of the ICA, crucial for collateral blood flow within the Circle of Willis. 2. Misidentifying vascular branches can have implications during neurosurgical or endovascular procedures. 3. Always correlate anatomical knowledge with imaging findings.\n\n**Current Evidence**\n\nModern neuroradiologic studies and anatomical texts continue to validate the branch patterns of the ICA. These anatomical details are essential in the context of ischemic and hemorrhagic cerebrovascular pathology and guide current interventional and surgical therapies.",
    "exam_year": "2018",
    "exam_type": "Promotion"
  }
]